weldinin
egis pharmaceuticals plc, maďarsko - sorafenib - 44 - cytostatica
sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastické činidlá - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
sorafenib sandoz 400 mg
sandoz pharmaceuticals d.d., slovinsko - sorafenib - 44 - cytostatica
sorafenib pharmagen
pharmagen cz s.r.o., Česká republika - sorafenib - 44 - cytostatica
irinotecan fresenius 20 mg/ml infúzny koncentrát
fresenius kabi s.r.o., Česká republika - irinotekán - 44 - cytostatica
zovudex 125 mg
berlin-chemie ag, nemecko - brivudín - 42 - chemotherapeutica (vratane tuberkulostatik)
irinotecan medac 20 mg/ml
medac gesellschaft für klinische spezialpräparate m.b.h., nemecko - irinotekán - 44 - cytostatica
irinotecan viatris 20 mg/ ml
viatris limited, Írsko - irinotekán - 44 - cytostatica
irinotecan kabi 20 mg/ ml infúzny koncentrát
fresenius kabi s.r.o., Česká republika - irinotekán - 44 - cytostatica
irinotecan accord 20 mg/ml koncentrát na infúzny roztok
accord healthcare polska sp. z o.o., poľsko - irinotekán - 44 - cytostatica